ZA732245B - Resolution of prostaglindin intermediates - Google Patents

Resolution of prostaglindin intermediates

Info

Publication number
ZA732245B
ZA732245B ZA732245A ZA732245A ZA732245B ZA 732245 B ZA732245 B ZA 732245B ZA 732245 A ZA732245 A ZA 732245A ZA 732245 A ZA732245 A ZA 732245A ZA 732245 B ZA732245 B ZA 732245B
Authority
ZA
South Africa
Prior art keywords
prostaglindin
intermediates
resolution
prostaglindin intermediates
Prior art date
Application number
ZA732245A
Other languages
English (en)
Inventor
B Magerlein
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ZA732245B publication Critical patent/ZA732245B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
ZA732245A 1972-04-27 1973-04-02 Resolution of prostaglindin intermediates ZA732245B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24799372A 1972-04-27 1972-04-27

Publications (1)

Publication Number Publication Date
ZA732245B true ZA732245B (en) 1974-03-27

Family

ID=22937208

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA732245A ZA732245B (en) 1972-04-27 1973-04-02 Resolution of prostaglindin intermediates

Country Status (7)

Country Link
JP (1) JPS5825668B2 (fr)
BE (1) BE798830A (fr)
CH (1) CH587811A5 (fr)
FR (1) FR2183036B1 (fr)
GB (2) GB1398347A (fr)
NL (1) NL7305434A (fr)
ZA (1) ZA732245B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5563397A (en) * 1978-10-31 1980-05-13 Mitsubishi Electric Corp Manufacture of bolling heat transmission surface
JPS61144268U (fr) * 1985-02-27 1986-09-05

Also Published As

Publication number Publication date
GB1398346A (en) 1975-06-18
JPS5825668B2 (ja) 1983-05-28
FR2183036A1 (fr) 1973-12-14
CH587811A5 (fr) 1977-05-13
JPS4947350A (fr) 1974-05-08
NL7305434A (fr) 1973-10-30
FR2183036B1 (fr) 1977-11-10
BE798830A (fr) 1973-10-29
GB1398347A (en) 1975-06-18

Similar Documents

Publication Publication Date Title
JPS5312818A (en) Preparation of substituted chloroacetoanilide
PH13325A (en) Prostaglandin intermediates
PH11102A (en) N-aminosulfenylated derivatives of carbofuran
ZA733016B (en) Preparation of thiocarbamylsulfenamides
GB1410518A (en) Preparation of printing surfaces
JPS5297958A (en) Production of intermediate of 155substituteddomegaa pentanoprostaglandine
IL40801A0 (en) Novel substituted ceph-3-ems
JPS56131569A (en) Manufacture of aminonicotinonitrile
ZA737995B (en) Preparation of phosphonothioureides
JPS5444657A (en) Manufacture of silylester of azetidinee22sulfenate
PH10325A (en) Synthesis or zearalanes ii intermediates
GB1410344A (en) Preparation of printing surfaces
GB1403502A (en) Prostaglandin intermediates
ZA73129B (en) Chemosterilization of ixodides
JPS5337625A (en) Preparation of substituted chloroacetoanilide
ZA732245B (en) Resolution of prostaglindin intermediates
GB1401350A (en) Resolution of dl-allethrolone
ZA726233B (en) Pharmaceutical intermediates
GB1368810A (en) Analysis of materials
ZA735959B (en) 4-ethers of 3-amino-5-sulfamoylbenzoic acids
AU5621973A (en) Derivatives of tetracyclines
GB1411713A (en) Manufacture of hollow cylinders
ZA73760B (en) Direct resolution 3-fluoro-dl-alanine
ZA733017B (en) Preparation of thiocarbamylsulfenamides
IL42607A0 (en) Preparation of difluoro-amines